The stock of NanoViricides Inc (NNVC) has seen a 6.61% increase in the past week, with a 10.26% gain in the past month, and a -11.64% decrease in the past quarter. The volatility ratio for the week is 10.81%, and the volatility levels for the past 30 days are at 10.16% for NNVC. The simple moving average for the last 20 days is -2.12% for NNVC stock, with a simple moving average of -21.29% for the last 200 days.
Is It Worth Investing in NanoViricides Inc (AMEX: NNVC) Right Now?
Company’s 36-month beta value is 0.93.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NNVC is 15.02M, and currently, short sellers hold a 0.94% ratio of that floaft. The average trading volume of NNVC on March 12, 2025 was 388.99K shares.
NNVC) stock’s latest price update
NanoViricides Inc (AMEX: NNVC) has seen a rise in its stock price by 11.21 in relation to its previous close of 1.16. However, the company has experienced a 6.61% gain in its stock price over the last five trading sessions. proactiveinvestors.com reported 2025-03-11 that NanoViricides (NYSE-A:NNVC) said on Tuesday that its business remains unaffected by US government tariffs, retaliatory trade policies, or federal spending cuts. In a statement, the clinical-stage biotech firm highlighted to shareholders that it develops antiviral treatments, not vaccines, and sees growing demand for broad-spectrum antiviral drugs under the policy direction of US Health and Human Services Secretary Robert Kennedy.
Analysts’ Opinion of NNVC
Many brokerage firms have already submitted their reports for NNVC stocks, with Midtown Partners repeating the rating for NNVC by listing it as a “Strong Buy.” The predicted price for NNVC in the upcoming period, according to Midtown Partners is $5.30 based on the research report published on February 11, 2015 of the previous year 2015.
NNVC Trading at 0.06% from the 50-Day Moving Average
After a stumble in the market that brought NNVC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.07% of loss for the given period.
Volatility was left at 10.16%, however, over the last 30 days, the volatility rate increased by 10.81%, as shares sank -1.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.57% lower at present.
During the last 5 trading sessions, NNVC rose by +6.61%, which changed the moving average for the period of 200-days by -40.83% in comparison to the 20-day moving average, which settled at $1.3180. In addition, NanoViricides Inc saw -9.79% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NNVC
The total capital return value is set at -0.92. Equity return is now at value -82.01, with -75.00 for asset returns.
Currently, EBITDA for the company is -7.76 million with net debt to EBITDA at 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.44.
Conclusion
In a nutshell, NanoViricides Inc (NNVC) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
